MacroGenics
Thomas Son is an experienced research manager at MacroGenics, a position held since May 2010, where expertise in cancer therapeutics and inflammation is applied. Prior roles include Associate Research Scientist at Exelixis, focusing on assay development for small molecule targets, and Research Associate at iScience Interventional, specializing in biochemical assays for age-related macular degeneration. Additionally, Thomas served as Senior Associate Scientist at ACADIA Pharmaceuticals, contributing to the understanding of neurological disorders through GPCR assays and effective communication with research teams. Thomas holds a Bachelor of Science degree in Biology from UC San Diego, earned in 1999.
MacroGenics
1 followers
MacroGenics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing monoclonal antibody-based therapeutics for the treatment of cancer, as well as various autoimmune disorders and infectious diseases. The Company devel...